graph TB
A[π Patient Clinical Data] --> B{π¬ Biomarker Validation}
B -->|β
Valid| C[π§ AI Neural Analysis]
B -->|β Invalid| D[β οΈ Data Quality Check]
D --> A
C --> E[π― Risk Stratification]
E --> F{π Risk Level Assessment}
F -->|π’ Low Risk| G[π Monitoring Protocol]
F -->|π‘ Medium Risk| H[β‘ Enhanced Screening]
F -->|π΄ High Risk| I[π¨ Immediate Intervention]
G --> J[π©ββοΈ Clinical Report]
H --> J
I --> J
J --> K[π₯ Healthcare Action Plan]
style A fill:#E3F2FD
style C fill:#FFF3E0
style E fill:#F3E5F5
style I fill:#FFEBEE
style K fill:#E8F5E8
|
|
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β π©Ί DIABETES RISK ASSESSMENT - CLINICAL REPORT β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ€
β Patient ID: #DM2024_HC001 β
β Analysis Date: 2025-01-XX XX:XX:XX GMT β
β Risk Classification: π΄ HIGH RISK (82.7%) β
β Clinical Confidence: 96.8% β
β Biomarker Status: β οΈ MULTIPLE INDICATORS ELEVATED β
β Recommendation: π¨ IMMEDIATE MEDICAL CONSULTATION β
β Follow-up: π
Schedule within 48 hours β
β Protocol: Enhanced monitoring & intervention required β
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Transforming Healthcare Through Artificial Intelligence |
|
|
|
|
Specialization: Healthcare AI β’ Medical Machine Learning β’ Clinical Data Science β’ Digital Health Innovation




